Curocell, Inc.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 2016-01-01
- Employees
- 102
- Market Cap
- -
- Website
- http://www.curocellbtx.com
Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma Patients
Phase 1
Recruiting
- Conditions
- Relapsed Large B-cell LymphomaHigh-grade B-cell LymphomaRefractory Large B-cell LymphomaDiffuse Large B-cell Lymphoma (DLBCL)Primary Mediastinal Large B-Cell Lymphoma (PMBCL)Transformed Follicular Lymphoma (TFL)
- Interventions
- First Posted Date
- 2021-04-08
- Last Posted Date
- 2021-05-03
- Lead Sponsor
- Curocell Inc.
- Target Recruit Count
- 91
- Registration Number
- NCT04836507
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath